ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$308.6M
Portfolio Weight
19.35%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$1.6B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$308.6M
Portfolio Weight
19.35%
KRSA
Common StockKorsana Biosciences, Inc.
Reported Shares
9.1M
Position Mix
No options reported
Reported Value
$291.3M
Portfolio Weight
18.27%
DNTH
Common StockDianthus Therapeutics, Inc. /DE/
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$223.4M
Portfolio Weight
14.01%
DMRA
Common StockDamora Therapeutics, Inc.
Reported Shares
8.7M
Position Mix
No options reported
Reported Value
$185.4M
Portfolio Weight
11.63%
COGT
Common StockCogent Biosciences, Inc.
Reported Shares
5.5M
Position Mix
No options reported
Reported Value
$176.2M
Portfolio Weight
11.05%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
5.1M
Position Mix
No options reported
Reported Value
$104.8M
Portfolio Weight
6.57%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$85.1M
Portfolio Weight
5.33%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$64.0M
Portfolio Weight
4.01%
ZBIO
Common StockZenas BioPharma, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$64.0M
Portfolio Weight
4.01%
CBIO
Common StockCRESCENT BIOPHARMA, INC.
Reported Shares
3.6M
Position Mix
No options reported
Reported Value
$52.5M
Portfolio Weight
3.30%
FTH
Common StockFaeth Therapeutics, Inc.
Reported Shares
722K
Position Mix
No options reported
Reported Value
$21.5M
Portfolio Weight
1.35%
IKT
Common StockInhibikase Therapeutics, Inc.
Reported Shares
8.6M
Position Mix
No options reported
Reported Value
$17.7M
Portfolio Weight
1.11%